SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2rsp'

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C6Y_B_MK1B524_1 (PROTEIN (PROTEASE))	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 11	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A 108	None	0.94A	1c6yA-2rspA: 12.7	1c6yA-2rspA: 29.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C6Y_B_MK1B524_2 (PROTEIN (PROTEASE))	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.29A	1c6yB-2rspA: 12.7	1c6yB-2rspA: 29.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C6Z_B_ROCB505_2 (PROTEIN (PROTEASE))	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	1.02A	1c6zB-2rspA: 12.6	1c6zB-2rspA: 29.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1D4Y_A_TPVA501_1 (PROTEIN (HIV-1 PROTEASE))	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ASP A  41	None	0.85A	1d4yA-2rspA: 12.8	1d4yA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1D4Y_A_TPVA501_2 (PROTEIN (HIV-1 PROTEASE))	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 8	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A 108	None	0.82A	1d4yB-2rspA: 12.9	1d4yB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FB7_A_ROCA100_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.32A	1fb7A-2rspA: 12.6	1fb7A-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1HSG_B_MK1B902_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A 108	None	0.91A	1hsgA-2rspA: 12.8	1hsgA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1HSG_B_MK1B902_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.84A	1hsgB-2rspA: 12.9	1hsgB-2rspA: 32.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HSH_A_MK1A401_1 (HIV-II PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  44 ILE A 108	None	0.46A	1hshA-2rspA: 12.5	1hshA-2rspA: 29.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HSH_C_MK1C402_1 (HIV-II PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.88A	1hshC-2rspA: 12.8	1hshC-2rspA: 29.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HSH_C_MK1C402_1 (HIV-II PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ILE A  44 ILE A 108	None	0.97A	1hshC-2rspA: 12.8	1hshC-2rspA: 29.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1HXB_A_ROCA100_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.28A	1hxbA-2rspA: 13.1	1hxbA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1HXB_A_ROCA100_3 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A 108	None	0.81A	1hxbB-2rspA: 13.1	1hxbB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1HXW_B_RITB301_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 11	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40	None	0.96A	1hxwB-2rspA: 12.7	1hxwB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1K6C_B_MK1B902_2 (POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.79A	1k6cB-2rspA: 13.0	1k6cB-2rspA: 32.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MMK_A_H4BA1427_1 (PHENYLALANINE-4-HYDR OXYLASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	VAL A  13 LEU A  35 LEU A  36 SER A  38 LEU A 121	None	1.14A	1mmkA-2rspA: undetectable	1mmkA-2rspA: 16.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MMT_A_H4BA1426_1 (PHENYLALANINE-4-HYDR OXYLASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 11	VAL A  13 LEU A  35 LEU A  36 SER A  38 LEU A 121	None	1.13A	1mmtA-2rspA: undetectable	1mmtA-2rspA: 16.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1MUI_B_AB1B100_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.32A	1muiA-2rspA: 13.0	1muiA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1MUI_B_AB1B100_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.93A	1muiB-2rspA: 12.9	1muiB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1OHR_A_1UNA201_1 (ASPARTYLPROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 11	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.34A	1ohrA-2rspA: 13.0	1ohrA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RL8_A_RITA9001_1 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.86A	1rl8A-2rspA: 12.8	1rl8A-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RL8_A_RITA9001_1 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A 105 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	1.48A	1rl8A-2rspA: 12.8	1rl8A-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RL8_A_RITA9001_2 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	7 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.91A	1rl8B-2rspA: 12.8	1rl8B-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1SDT_B_MK1B902_2 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.38A	1sdtB-2rspA: 12.7	1sdtB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1SDU_B_MK1B902_1 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 11	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A 108	None	0.83A	1sduA-2rspA: 12.9	1sduA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1SDU_B_MK1B902_2 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.87A	1sduB-2rspA: 12.7	1sduB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1SDV_B_MK1B902_1 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A 108	None	0.87A	1sdvA-2rspA: 12.7	1sdvA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1SDV_B_MK1B902_2 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 11	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.34A	1sdvB-2rspA: 12.7	1sdvB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1SGU_B_MK1B2632_2 (POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  44	None	0.82A	1sguB-2rspA: 12.9	1sguB-2rspA: 32.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1T3R_A_017A1200_1 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.25A	1t3rA-2rspA: 12.9	1t3rA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1T7I_A_017A200_1 (POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.23A	1t7iA-2rspA: 12.9	1t7iA-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1T7J_A_478A200_1 (POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 11	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.27A	1t7jA-2rspA: 12.9	1t7jA-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2AQU_B_DR7B300_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 10	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.89A	2aquA-2rspA: 12.9	2aquA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2AQU_B_DR7B300_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 10	ARG A 105 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	1.47A	2aquA-2rspA: 12.9	2aquA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2AQU_B_DR7B300_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.88A	2aquB-2rspA: 12.9	2aquB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2AVO_B_MK1B902_2 (POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.36A	2avoB-2rspA: 12.8	2avoB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2AVS_B_MK1B902_1 (POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.87A	2avsA-2rspA: 12.9	2avsA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2AVS_B_MK1B902_3 (POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 ASP A  37 ALA A  40 ASP A  41 ILE A 108	None	0.93A	2avsB-2rspA: 12.8	2avsB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2AVS_B_MK1B902_3 (POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.37A	2avsB-2rspA: 12.8	2avsB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2AVV_A_MK1A901_1 (POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.85A	2avvA-2rspA: 12.9	2avvA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2AVV_A_MK1A901_3 (POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.36A	2avvB-2rspA: 12.9	2avvB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2AVV_E_MK1E902_1 (POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.83A	2avvD-2rspA: 12.9	2avvD-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2AVV_E_MK1E902_3 (POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.38A	2avvE-2rspA: 12.9	2avvE-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2B60_B_RITB100_1 (GAG-POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  44 ILE A 108	None	0.45A	2b60A-2rspA: 12.9	2b60A-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2B60_B_RITB100_2 (GAG-POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 11	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.81A	2b60B-2rspA: 12.8	2b60B-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2B60_B_RITB100_2 (GAG-POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  44 ILE A 108	None	0.49A	2b60B-2rspA: 12.8	2b60B-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2B7Z_B_MK1B200_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.76A	2b7zA-2rspA: 12.9	2b7zA-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2B7Z_B_MK1B200_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.76A	2b7zB-2rspA: 12.8	2b7zB-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BPX_B_MK1B902_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.32A	2bpxB-2rspA: 12.9	2bpxB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2F80_B_017B301_1 (POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.32A	2f80A-2rspA: 12.6	2f80A-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2F80_B_017B301_2 (POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.35A	2f80B-2rspA: 12.7	2f80B-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2F81_A_017A302_1 (POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.41A	2f81A-2rspA: 12.6	2f81A-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2F81_A_017A302_2 (POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.44A	2f81B-2rspA: 12.6	2f81B-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2F8G_B_017B401_1 (POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.35A	2f8gA-2rspA: 12.7	2f8gA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2F8G_B_017B401_2 (POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.51A	2f8gB-2rspA: 12.6	2f8gB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2FXD_A_DR7A102_1 (POL PROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 11	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.81A	2fxdA-2rspA: 12.3	2fxdA-2rspA: 30.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2FXD_A_DR7A102_1 (POL PROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 11	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.28A	2fxdA-2rspA: 12.3	2fxdA-2rspA: 30.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2FXD_A_DR7A102_2 (POL PROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	4 / 7	ARG A  10 ASP A  37 ALA A  40 ASP A  41	None	0.74A	2fxdB-2rspA: 12.6	2fxdB-2rspA: 30.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2FXE_A_DR7A102_1 (POL PROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.87A	2fxeA-2rspA: 12.8	2fxeA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2FXE_A_DR7A102_1 (POL PROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A 105 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	1.39A	2fxeA-2rspA: 12.8	2fxeA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2FXE_A_DR7A102_2 (POL PROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.87A	2fxeB-2rspA: 12.8	2fxeB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2FXE_A_DR7A102_2 (POL PROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	ARG A 105 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	1.47A	2fxeB-2rspA: 12.8	2fxeB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HS1_A_017A201_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  44 ILE A 108	None	0.41A	2hs1A-2rspA: 12.7	2hs1A-2rspA: 34.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HS1_A_017A201_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A  44 ILE A 108	None	0.86A	2hs1B-2rspA: 12.7	2hs1B-2rspA: 34.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HS1_A_017A201_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A  44 ILE A 108	None	0.33A	2hs1B-2rspA: 12.7	2hs1B-2rspA: 34.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HS2_A_017A201_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.24A	2hs2A-2rspA: 12.7	2hs2A-2rspA: 32.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HS2_A_017A201_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A 108	None	0.91A	2hs2B-2rspA: 12.7	2hs2B-2rspA: 32.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HS2_A_017A201_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.31A	2hs2B-2rspA: 12.7	2hs2B-2rspA: 32.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2IDW_B_017B401_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 9	LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A  71 ILE A 108	None	1.25A	2idwB-2rspA: 12.7	2idwB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2IDW_B_017B401_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 9	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.46A	2idwB-2rspA: 12.7	2idwB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2IEN_B_017B402_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A 108	None	1.48A	2ienA-2rspA: 12.6	2ienA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2IEN_B_017B402_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.92A	2ienA-2rspA: 12.6	2ienA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2IEN_B_017B402_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.44A	2ienB-2rspA: 12.7	2ienB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2IEO_A_017A402_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.88A	2ieoA-2rspA: 12.6	2ieoA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2IEO_A_017A402_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A 105 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	1.47A	2ieoA-2rspA: 12.6	2ieoA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2IEO_A_017A402_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.19A	2ieoB-2rspA: 12.7	2ieoB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2NMY_A_ROCA401_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.90A	2nmyA-2rspA: 12.4	2nmyA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2NMY_A_ROCA401_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A 105 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	1.41A	2nmyA-2rspA: 12.4	2nmyA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2NMY_A_ROCA401_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40	None	0.88A	2nmyB-2rspA: 12.5	2nmyB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2NMY_A_ROCA401_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A 105 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	1.43A	2nmyB-2rspA: 12.5	2nmyB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2NMZ_B_ROCB401_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A  71 ILE A 108	None	1.28A	2nmzA-2rspA: 12.9	2nmzA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2NMZ_B_ROCB401_3 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.87A	2nmzB-2rspA: 12.7	2nmzB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2NMZ_B_ROCB401_3 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A 105 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	1.44A	2nmzB-2rspA: 12.7	2nmzB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2NNK_A_ROCA401_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.22A	2nnkA-2rspA: 12.6	2nnkA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2NNK_A_ROCA401_3 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ASP A  41	None	0.89A	2nnkB-2rspA: 12.7	2nnkB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2O4K_A_DR7A301_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ASP A  41	None	0.85A	2o4kA-2rspA: 12.6	2o4kA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2O4K_A_DR7A301_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A 108	None	0.40A	2o4kA-2rspA: 12.6	2o4kA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2O4K_A_DR7A301_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.79A	2o4kB-2rspA: 12.8	2o4kB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2O4K_A_DR7A301_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A 105 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	1.50A	2o4kB-2rspA: 12.8	2o4kB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2O4L_A_TPVA403_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A 108	None	0.82A	2o4lA-2rspA: 12.8	2o4lA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2O4L_A_TPVA403_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	7 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.78A	2o4lB-2rspA: 12.9	2o4lB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2O4L_A_TPVA403_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	7 / 12	ARG A 105 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	1.50A	2o4lB-2rspA: 12.9	2o4lB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2O4N_A_TPVA300_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A  44	None	0.88A	2o4nA-2rspA: 12.8	2o4nA-2rspA: 35.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2O4P_A_TPVA300_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 11	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ASP A  41	None	0.82A	2o4pA-2rspA: 12.8	2o4pA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2O4P_A_TPVA300_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 9	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A 108	None	0.88A	2o4pB-2rspA: 12.8	2o4pB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2O4S_A_AB1A400_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.36A	2o4sA-2rspA: 12.7	2o4sA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2O4S_A_AB1A400_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.80A	2o4sB-2rspA: 12.8	2o4sB-2rspA: 33.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OUZ_A_C3DA999_0 (ESTROGEN RECEPTOR)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A 119 LEU A 109 LEU A  36 LEU A  12 ILE A  32 LEU A  82	None	1.45A	2ouzA-2rspA: undetectable	2ouzA-2rspA: 17.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2PYM_A_1UNA1001_1 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.21A	2pymA-2rspA: 12.9	2pymA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2PYM_A_1UNA1001_2 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A 108	None	0.91A	2pymB-2rspA: 12.9	2pymB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2PYM_A_1UNA1001_2 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.23A	2pymB-2rspA: 12.9	2pymB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2PYN_A_1UNA1001_1 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.21A	2pynA-2rspA: 13.2	2pynA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2PYN_A_1UNA1001_2 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A 108	None	0.86A	2pynB-2rspA: 13.2	2pynB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2PYN_A_1UNA1001_2 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.22A	2pynB-2rspA: 13.2	2pynB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2Q5K_A_AB1A201_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.84A	2q5kB-2rspA: 12.8	2q5kB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2Q63_A_1UNA1001_1 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.23A	2q63A-2rspA: 12.8	2q63A-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2Q63_A_1UNA1001_3 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.24A	2q63B-2rspA: 12.8	2q63B-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2Q64_B_1UNB1001_1 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.35A	2q64A-2rspA: 13.0	2q64A-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2Q64_B_1UNB1001_3 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.40A	2q64B-2rspA: 12.9	2q64B-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2QAK_A_1UNA1001_1 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.38A	2qakA-2rspA: 12.7	2qakA-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2QAK_A_1UNA1001_3 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A 108	None	0.86A	2qakB-2rspA: 12.7	2qakB-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2QAK_A_1UNA1001_3 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.23A	2qakB-2rspA: 12.7	2qakB-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2QHC_B_AB1B9001_1 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 11	ARG A  10 ASP A  37 ALA A  40 ASP A  41 ILE A 108	None	0.81A	2qhcA-2rspA: 13.0	2qhcA-2rspA: 31.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2QHC_B_AB1B9001_2 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 ASP A  37 ALA A  40 ASP A  41 ILE A 108	None	0.87A	2qhcB-2rspA: 12.8	2qhcB-2rspA: 31.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2QHC_B_AB1B9001_2 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.25A	2qhcB-2rspA: 12.8	2qhcB-2rspA: 31.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2R5P_B_MK1B902_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.86A	2r5pB-2rspA: 12.8	2r5pB-2rspA: 34.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2R5P_D_MK1D902_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.86A	2r5pD-2rspA: 12.8	2r5pD-2rspA: 34.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2R5Q_B_1UNB900_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 11	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.28A	2r5qB-2rspA: 12.6	2r5qB-2rspA: 34.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2R5Q_D_1UND900_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.28A	2r5qD-2rspA: 12.6	2r5qD-2rspA: 34.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2RKF_A_AB1A501_1 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	7 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  44 ILE A 108	None	0.38A	2rkfA-2rspA: 13.0	2rkfA-2rspA: 30.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2RKF_A_AB1A501_2 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A  71 ILE A 108	None	1.36A	2rkfB-2rspA: 13.0	2rkfB-2rspA: 30.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2RKF_A_AB1A501_2 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	7 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  44 ILE A 108	None	0.36A	2rkfB-2rspA: 13.0	2rkfB-2rspA: 30.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2RKG_B_AB1B501_1 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A  71 ILE A 108	None	1.39A	2rkgA-2rspA: 13.3	2rkgA-2rspA: 31.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2RKG_B_AB1B501_1 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	7 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  44 ILE A 108	None	0.42A	2rkgA-2rspA: 13.3	2rkgA-2rspA: 31.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2RKG_B_AB1B501_2 (PROTEASE RETROPEPSIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	7 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  44 ILE A 108	None	0.40A	2rkgB-2rspA: 13.3	2rkgB-2rspA: 31.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2Z54_A_AB1A200_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 ASP A  37 ALA A  40 ASP A  41 ILE A 108	None	0.93A	2z54A-2rspA: 12.9	2z54A-2rspA: 30.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2Z54_A_AB1A200_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.39A	2z54A-2rspA: 12.9	2z54A-2rspA: 30.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2Z54_A_AB1A200_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.87A	2z54B-2rspA: 12.9	2z54B-2rspA: 30.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BVB_B_017B401_2 (PROTEASE (RETROPEPSIN))	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.44A	3bvbB-2rspA: 12.7	3bvbB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CYW_A_017A201_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.45A	3cywA-2rspA: 12.6	3cywA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CYW_A_017A201_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.40A	3cywA-2rspA: 12.6	3cywA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CYW_A_017A201_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.43A	3cywB-2rspA: 12.7	3cywB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CYX_A_ROCA201_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.29A	3cyxA-2rspA: 12.7	3cyxA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D1X_A_ROCA201_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.31A	3d1xA-2rspA: 12.7	3d1xA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D1X_A_ROCA201_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40	None	0.86A	3d1xB-2rspA: 12.8	3d1xB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D1X_A_ROCA201_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.38A	3d1xB-2rspA: 12.8	3d1xB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D1Y_A_ROCA201_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.45A	3d1yA-2rspA: 12.7	3d1yA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D1Z_B_017B201_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.42A	3d1zB-2rspA: 12.8	3d1zB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D20_A_017A201_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.44A	3d20A-2rspA: 12.7	3d20A-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3D20_A_017A201_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.42A	3d20B-2rspA: 12.7	3d20B-2rspA: 32.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EBZ_B_017B201_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A  44 ILE A 108	None	0.87A	3ebzA-2rspA: 12.7	3ebzA-2rspA: 29.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EBZ_B_017B201_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  44	None	0.42A	3ebzB-2rspA: 12.8	3ebzB-2rspA: 29.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EKP_C_478C200_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.51A	3ekpD-2rspA: 12.8	3ekpD-2rspA: 31.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EKQ_A_ROCA100_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.46A	3ekqA-2rspA: 12.8	3ekqA-2rspA: 31.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EKT_B_017B200_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 9	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.25A	3ektA-2rspA: 12.9	3ektA-2rspA: 31.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EKT_D_017D200_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A  71 ILE A 108	None	1.34A	3ektC-2rspA: 13.0	3ektC-2rspA: 31.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EKT_D_017D200_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.44A	3ektC-2rspA: 13.0	3ektC-2rspA: 31.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EKT_D_017D200_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.44A	3ektD-2rspA: 13.0	3ektD-2rspA: 31.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EKV_A_478A200_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 10	LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A  71 ILE A 108	None	1.31A	3ekvA-2rspA: 12.9	3ekvA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EKV_A_478A200_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 10	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.45A	3ekvA-2rspA: 12.9	3ekvA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EKW_B_DR7B100_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	ARG A  10 ASP A  37 ALA A  40 ASP A  41 ILE A 108	None	0.90A	3ekwA-2rspA: 12.8	3ekwA-2rspA: 31.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EKW_B_DR7B100_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.83A	3ekwB-2rspA: 12.9	3ekwB-2rspA: 31.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EKX_B_1UNB201_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 11	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.15A	3ekxA-2rspA: 13.0	3ekxA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EKY_A_DR7A100_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 10	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	1.04A	3ekyA-2rspA: 12.8	3ekyA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EL0_A_1UNA201_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 8	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.44A	3el0A-2rspA: 12.8	3el0A-2rspA: 31.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EL1_A_DR7A100_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.86A	3el1A-2rspA: 13.0	3el1A-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EL1_A_DR7A100_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.37A	3el1A-2rspA: 13.0	3el1A-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EL1_A_DR7A100_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.90A	3el1B-2rspA: 13.1	3el1B-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EL9_A_DR7A100_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	4 / 8	ARG A  10 ASP A  37 ALA A  40 ASP A  41	None	0.79A	3el9A-2rspA: 12.9	3el9A-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EL9_A_DR7A100_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.84A	3el9B-2rspA: 12.9	3el9B-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EM3_B_478B200_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.42A	3em3A-2rspA: 13.0	3em3A-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EM4_A_DR7A100_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.77A	3em4A-2rspA: 12.8	3em4A-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EM4_V_DR7V100_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 11	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.85A	3em4U-2rspA: 12.9	3em4U-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EM4_V_DR7V100_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	ARG A 105 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	1.45A	3em4U-2rspA: 12.9	3em4U-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EM6_A_017A200_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A 108	None	0.96A	3em6B-2rspA: 12.8	3em6B-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GGU_B_017B201_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 9	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.24A	3gguB-2rspA: 12.9	3gguB-2rspA: 30.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JVY_B_017B401_1 (GAG-POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.31A	3jvyA-2rspA: 12.6	3jvyA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JVY_B_017B401_2 (GAG-POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.36A	3jvyB-2rspA: 12.6	3jvyB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JW2_A_017A401_1 (GAG-POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A  71 ILE A 108	None	1.39A	3jw2A-2rspA: 12.6	3jw2A-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JW2_A_017A401_1 (GAG-POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 ALA A  40 ASP A 112 ILE A  71 ILE A 108	None	1.45A	3jw2A-2rspA: 12.6	3jw2A-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JW2_A_017A401_1 (GAG-POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.32A	3jw2A-2rspA: 12.6	3jw2A-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JW2_A_017A401_1 (GAG-POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A 112 ILE A 108	None	1.23A	3jw2A-2rspA: 12.6	3jw2A-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JW2_A_017A401_2 (GAG-POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A  71 ILE A 108	None	1.31A	3jw2B-2rspA: 12.7	3jw2B-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JW2_A_017A401_2 (GAG-POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.31A	3jw2B-2rspA: 12.7	3jw2B-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3K4V_B_ROCB201_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.38A	3k4vA-2rspA: 12.7	3k4vA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3K4V_B_ROCB201_3 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.37A	3k4vB-2rspA: 12.6	3k4vB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3K4V_D_ROCD201_3 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.43A	3k4vD-2rspA: 12.5	3k4vD-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LZS_A_017A200_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.40A	3lzsA-2rspA: 12.9	3lzsA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LZS_A_017A200_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.51A	3lzsB-2rspA: 12.8	3lzsB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LZU_A_017A200_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.48A	3lzuA-2rspA: 12.8	3lzuA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LZU_A_017A200_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A  71 ILE A 108	None	1.38A	3lzuB-2rspA: 12.7	3lzuB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LZU_A_017A200_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.48A	3lzuB-2rspA: 12.7	3lzuB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LZV_A_017A200_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.27A	3lzvA-2rspA: 13.0	3lzvA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MWS_B_017B201_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A  71	None	0.99A	3mwsA-2rspA: 12.7	3mwsA-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MWS_B_017B201_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.29A	3mwsA-2rspA: 12.7	3mwsA-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NDT_A_ROCA101_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.40A	3ndtA-2rspA: 12.7	3ndtA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NDT_A_ROCA101_3 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.36A	3ndtB-2rspA: 12.8	3ndtB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NDT_D_ROCD100_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40	None	0.86A	3ndtC-2rspA: 12.7	3ndtC-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NDT_D_ROCD100_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.35A	3ndtC-2rspA: 12.7	3ndtC-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NDT_D_ROCD100_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.44A	3ndtD-2rspA: 12.6	3ndtD-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NDU_A_ROCA101_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.40A	3nduA-2rspA: 12.6	3nduA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NDU_A_ROCA101_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.36A	3nduB-2rspA: 12.7	3nduB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NDU_D_ROCD100_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.44A	3nduD-2rspA: 12.1	3nduD-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NDW_A_RITA100_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.87A	3ndwA-2rspA: 12.9	3ndwA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NDW_A_RITA100_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.38A	3ndwA-2rspA: 12.9	3ndwA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NDX_A_RITA100_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.85A	3ndxA-2rspA: 12.9	3ndxA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NDX_A_RITA100_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.37A	3ndxA-2rspA: 12.9	3ndxA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NDX_A_RITA100_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.86A	3ndxB-2rspA: 12.7	3ndxB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NDX_A_RITA100_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	ARG A 105 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	1.48A	3ndxB-2rspA: 12.7	3ndxB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NU3_B_478B401_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.33A	3nu3A-2rspA: 12.6	3nu3A-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NU3_B_478B401_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 11	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.43A	3nu3B-2rspA: 12.7	3nu3B-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NU4_B_478B401_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 9	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A  44 ILE A 108	None	0.38A	3nu4B-2rspA: 12.7	3nu4B-2rspA: 34.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NU5_B_478B401_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.33A	3nu5A-2rspA: 12.6	3nu5A-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NU5_B_478B401_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.39A	3nu5B-2rspA: 12.7	3nu5B-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NU6_B_478B401_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.42A	3nu6B-2rspA: 12.8	3nu6B-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NUJ_B_478B401_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 9	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.39A	3nujB-2rspA: 12.7	3nujB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NUO_B_478B478_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 9	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.46A	3nuoB-2rspA: 12.6	3nuoB-2rspA: 32.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OGP_A_017A200_1 (FIV PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 9	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  42	None	0.26A	3ogpA-2rspA: 12.2	3ogpA-2rspA: 26.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OGP_B_017B200_2 (FIV PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 9	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  42	None	0.19A	3ogpB-2rspA: 12.2	3ogpB-2rspA: 26.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OGQ_A_AB1A200_1 (FIV PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A  42	None	0.40A	3ogqA-2rspA: 12.1	3ogqA-2rspA: 26.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OGQ_A_AB1A200_2 (FIV PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	7 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  42	None	0.97A	3ogqB-2rspA: 12.6	3ogqB-2rspA: 26.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXC_A_ROCA401_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.38A	3oxcA-2rspA: 12.8	3oxcA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXC_A_ROCA401_3 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40	None	0.88A	3oxcB-2rspA: 12.7	3oxcB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXC_A_ROCA401_3 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.57A	3oxcB-2rspA: 12.7	3oxcB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXV_B_478B200_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 9	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.40A	3oxvA-2rspA: 13.0	3oxvA-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXV_C_478C200_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 9	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.41A	3oxvC-2rspA: 12.9	3oxvC-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXW_B_017B200_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.20A	3oxwA-2rspA: 12.9	3oxwA-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXW_D_017D200_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.21A	3oxwC-2rspA: 13.0	3oxwC-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXX_A_DR7A100_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.85A	3oxxA-2rspA: 12.9	3oxxA-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXX_A_DR7A100_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A 105 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	1.45A	3oxxA-2rspA: 12.9	3oxxA-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXX_A_DR7A100_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.37A	3oxxA-2rspA: 12.9	3oxxA-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXX_A_DR7A100_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 11	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ASP A  41	None	0.84A	3oxxB-2rspA: 13.2	3oxxB-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXX_A_DR7A100_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	ARG A 105 LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A 108	None	1.47A	3oxxB-2rspA: 13.2	3oxxB-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXX_C_DR7C100_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.84A	3oxxC-2rspA: 12.8	3oxxC-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXX_C_DR7C100_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A 105 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	1.39A	3oxxC-2rspA: 12.8	3oxxC-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXX_C_DR7C100_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.38A	3oxxC-2rspA: 12.8	3oxxC-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXX_C_DR7C100_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 11	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ASP A  41	None	0.84A	3oxxD-2rspA: 13.2	3oxxD-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXX_C_DR7C100_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	ARG A 105 LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A 108	None	1.47A	3oxxD-2rspA: 13.2	3oxxD-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OY4_B_017B200_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.25A	3oy4B-2rspA: 12.8	3oy4B-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PWM_B_017B402_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.38A	3pwmA-2rspA: 12.6	3pwmA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PWM_B_017B402_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.44A	3pwmB-2rspA: 12.7	3pwmB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PWR_A_ROCA401_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.43A	3pwrA-2rspA: 12.6	3pwrA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PWR_A_ROCA401_3 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40	None	0.89A	3pwrB-2rspA: 12.7	3pwrB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PWR_A_ROCA401_3 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.36A	3pwrB-2rspA: 12.7	3pwrB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3S43_A_478A401_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 10	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A  44 ILE A 108	None	0.37A	3s43B-2rspA: 12.7	3s43B-2rspA: 33.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3S45_B_478B201_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  44 ILE A 108	None	0.53A	3s45B-2rspA: 12.9	3s45B-2rspA: 29.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3S45_B_478B201_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.40A	3s45B-2rspA: 12.9	3s45B-2rspA: 29.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3S53_A_017A201_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 9	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  44	None	0.24A	3s53A-2rspA: 12.7	3s53A-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3S53_A_017A201_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A  44 ILE A 108	None	0.87A	3s53B-2rspA: 12.6	3s53B-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3S54_B_017B201_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.88A	3s54A-2rspA: 12.7	3s54A-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3S54_B_017B201_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A  71 ILE A 108	None	1.31A	3s54B-2rspA: 12.7	3s54B-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3S54_B_017B201_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.32A	3s54B-2rspA: 12.7	3s54B-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3S56_A_ROCA201_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  44	None	0.28A	3s56A-2rspA: 12.1	3s56A-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3T3C_A_017A201_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	4 / 7	ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.18A	3t3cA-2rspA: 12.8	3t3cA-2rspA: 31.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TKG_B_ROCB801_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.35A	3tkgA-2rspA: 11.4	3tkgA-2rspA: 31.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TKG_B_ROCB801_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40	None	0.85A	3tkgB-2rspA: 12.7	3tkgB-2rspA: 31.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TKG_B_ROCB801_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.39A	3tkgB-2rspA: 12.7	3tkgB-2rspA: 31.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TKG_C_ROCC901_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.45A	3tkgC-2rspA: 12.3	3tkgC-2rspA: 31.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TKG_C_ROCC901_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40	None	0.86A	3tkgD-2rspA: 12.6	3tkgD-2rspA: 31.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TKW_B_017B401_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.40A	3tkwA-2rspA: 12.7	3tkwA-2rspA: 31.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TKW_B_017B401_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.39A	3tkwB-2rspA: 11.8	3tkwB-2rspA: 31.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TL9_A_ROCA401_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.45A	3tl9A-2rspA: 12.8	3tl9A-2rspA: 31.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TL9_A_ROCA401_3 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.84A	3tl9B-2rspA: 11.9	3tl9B-2rspA: 31.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TL9_A_ROCA401_3 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A 105 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	1.41A	3tl9B-2rspA: 11.9	3tl9B-2rspA: 31.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TTP_A_017A201_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.41A	3ttpA-2rspA: 13.3	3ttpA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TTP_A_017A201_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.44A	3ttpB-2rspA: 13.3	3ttpB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3U7S_A_017A201_1 (POL POLYPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 9	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.25A	3u7sA-2rspA: 12.9	3u7sA-2rspA: 32.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UCB_A_017A201_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  44	None	0.27A	3ucbA-2rspA: 12.9	3ucbA-2rspA: 30.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UCB_A_017A201_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  44	None	0.25A	3ucbB-2rspA: 12.7	3ucbB-2rspA: 30.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WSJ_A_MK1A201_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 9	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A 108	None	0.86A	3wsjA-2rspA: 13.0	3wsjA-2rspA: 29.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WSJ_A_MK1A201_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 7	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A 108	None	0.84A	3wsjB-2rspA: 13.2	3wsjB-2rspA: 29.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C9N_A_CAMA1419_0 (CYTOCHROME P450)	2rsp	RSV PROTEASE (Rous sarcoma virus)	4 / 8	LEU A  95 LEU A  82 GLY A  83 VAL A  13	None	0.85A	4c9nA-2rspA: undetectable	4c9nA-2rspA: 17.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DQB_B_017B101_2 (ASPARTYL PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.26A	4dqbB-2rspA: 12.7	4dqbB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DQC_A_017A101_2 (ASPARTYL PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 9	LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A  71	None	1.04A	4dqcB-2rspA: 12.8	4dqcB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DQC_A_017A101_2 (ASPARTYL PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 9	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.24A	4dqcB-2rspA: 12.8	4dqcB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DQE_B_017B101_1 (ASPARTYL PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 11	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A 108	None	0.87A	4dqeA-2rspA: 12.7	4dqeA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DQE_B_017B101_2 (ASPARTYL PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.24A	4dqeB-2rspA: 12.8	4dqeB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DQF_B_017B101_1 (ASPARTYL PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A 108	None	0.93A	4dqfA-2rspA: 12.4	4dqfA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DQF_B_017B101_2 (ASPARTYL PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 10	LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A  71 ILE A 108	None	1.26A	4dqfB-2rspA: 12.9	4dqfB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DQF_B_017B101_2 (ASPARTYL PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 10	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.46A	4dqfB-2rspA: 12.9	4dqfB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DQH_B_017B101_2 (WILD-TYPE HIV-1 PROTEASE DIMER)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.26A	4dqhB-2rspA: 12.7	4dqhB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4HLA_A_017A200_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.37A	4hlaA-2rspA: 12.9	4hlaA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4HLA_A_017A200_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.27A	4hlaA-2rspA: 12.9	4hlaA-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4HLA_A_017A200_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.39A	4hlaB-2rspA: 12.9	4hlaB-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4JEC_B_478B401_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A  71 ILE A 108	None	1.33A	4jecA-2rspA: 12.8	4jecA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4JEC_B_478B401_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.36A	4jecA-2rspA: 12.8	4jecA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4JEC_B_478B401_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.38A	4jecB-2rspA: 12.7	4jecB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LL3_A_017A201_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 10	LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A  71 ILE A 108	None	1.31A	4ll3B-2rspA: 12.9	4ll3B-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LL3_A_017A201_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 10	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.44A	4ll3B-2rspA: 12.9	4ll3B-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LL3_A_017A202_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 10	LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A  71 ILE A 108	None	1.32A	4ll3A-2rspA: 12.9	4ll3A-2rspA: 32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LL3_A_017A202_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 10	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.45A	4ll3A-2rspA: 12.9	4ll3A-2rspA: 32.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJT_B_017B101_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.27A	4njtB-2rspA: 13.0	4njtB-2rspA: 29.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJT_D_017D101_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 9	LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A  71	None	1.07A	4njtD-2rspA: 12.9	4njtD-2rspA: 29.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJT_D_017D101_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 9	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.27A	4njtD-2rspA: 12.9	4njtD-2rspA: 29.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJU_A_TPVA500_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ASP A  41	None	0.79A	4njuA-2rspA: 12.8	4njuA-2rspA: 29.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJU_A_TPVA500_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A 108	None	0.81A	4njuB-2rspA: 13.2	4njuB-2rspA: 29.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJU_C_TPVC500_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ASP A  41	None	0.78A	4njuC-2rspA: 12.8	4njuC-2rspA: 29.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJU_C_TPVC500_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 10	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A 108	None	0.81A	4njuD-2rspA: 13.2	4njuD-2rspA: 29.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJV_A_RITA500_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.86A	4njvA-2rspA: 12.7	4njvA-2rspA: 29.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJV_A_RITA500_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.35A	4njvA-2rspA: 12.7	4njvA-2rspA: 29.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4Q1W_A_017A104_1 (ASPARTYL PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 9	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.29A	4q1wA-2rspA: 12.9	4q1wA-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4Q1X_A_017A101_1 (ASPARTYL PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 11	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  44	None	0.32A	4q1xA-2rspA: 12.9	4q1xA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4Q1X_A_017A101_2 (ASPARTYL PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A  44 ILE A 108	None	0.96A	4q1xB-2rspA: 12.7	4q1xB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4Q1Y_A_017A106_1 (ASPARTYL PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 10	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  44	None	0.30A	4q1yA-2rspA: 13.0	4q1yA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4Q1Y_A_017A106_2 (ASPARTYL PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A  44 ILE A 108	None	0.90A	4q1yB-2rspA: 12.8	4q1yB-2rspA: 33.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RVJ_B_478B101_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 9	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.45A	4rvjB-2rspA: 13.0	4rvjB-2rspA: 29.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RVJ_D_478D101_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 9	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.44A	4rvjD-2rspA: 13.0	4rvjD-2rspA: 29.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5E5J_A_017A201_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	7 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  44 ILE A 108	None	0.33A	5e5jA-2rspA: 12.8	5e5jA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5E5J_A_017A201_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	7 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A  44 ILE A 108	None	0.85A	5e5jB-2rspA: 12.8	5e5jB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5E5K_B_017B201_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A  71 ILE A 108	None	1.30A	5e5kA-2rspA: 12.8	5e5kA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5E5K_B_017B201_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	7 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  44 ILE A 108	None	0.35A	5e5kA-2rspA: 12.8	5e5kA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5E5K_B_017B201_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	7 / 12	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A  44 ILE A 108	None	0.84A	5e5kB-2rspA: 12.7	5e5kB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5E5K_B_017B201_2 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	7 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  44 ILE A 108	None	0.34A	5e5kB-2rspA: 12.7	5e5kB-2rspA: 33.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GQB_A_GCSA605_1 (CHITINASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	3 / 3	TRP A  50 ILE A  32 SER A 107	None	0.61A	5gqbA-2rspA: undetectable	5gqbA-2rspA: 12.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5T2Z_B_017B201_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.22A	5t2zA-2rspA: 12.9	5t2zA-2rspA: 28.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5T2Z_B_017B201_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.43A	5t2zB-2rspA: 12.9	5t2zB-2rspA: 28.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5T8H_B_478B401_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	7 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A  44 ILE A 108	None	0.35A	5t8hA-2rspA: 12.8	5t8hA-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5T8H_B_478B401_2 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	7 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A  44 ILE A 108	None	0.83A	5t8hB-2rspA: 12.8	5t8hB-2rspA: 33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DGX_A_017A101_0 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.48A	6dgxA-2rspA: 12.9	6dgxA-2rspA: 30.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DGX_A_017A101_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A 108	None	0.93A	6dgxB-2rspA: 12.8	6dgxB-2rspA: 30.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DH0_A_017A101_0 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.35A	6dh0A-2rspA: 12.9	6dh0A-2rspA: 30.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DH3_A_017A101_0 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.45A	6dh3A-2rspA: 12.8	6dh3A-2rspA: 30.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DH3_A_017A101_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.90A	6dh3B-2rspA: 9.6	6dh3B-2rspA: 30.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DH6_A_017A104_0 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.49A	6dh6A-2rspA: 12.8	6dh6A-2rspA: 30.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DH6_A_017A104_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ILE A 108	None	0.94A	6dh6B-2rspA: 12.8	6dh6B-2rspA: 30.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DH6_A_017A104_1 (PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.41A	6dh6B-2rspA: 12.8	6dh6B-2rspA: 30.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DIF_B_TPVB201_0 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ASP A  41 ILE A 108	None	0.82A	6difA-2rspA: 12.7	6difA-2rspA: 30.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DIF_B_TPVB201_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.79A	6difB-2rspA: 12.8	6difB-2rspA: 30.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DIL_B_TPVB201_0 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 LEU A  35 ASP A  37 ALA A  40 ASP A  41	None	0.81A	6dilA-2rspA: 12.7	6dilA-2rspA: 30.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DIL_B_TPVB201_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A  10 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	0.81A	6dilB-2rspA: 12.8	6dilB-2rspA: 30.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DIL_B_TPVB201_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	6 / 12	ARG A 105 LEU A  35 ASP A  37 GLY A  39 ALA A  40 ILE A 108	None	1.49A	6dilB-2rspA: 12.8	6dilB-2rspA: 30.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DJ1_B_AB1B201_0 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ASP A  37 GLY A  39 ALA A  40 ASP A  41 ILE A 108	None	0.35A	6dj1A-2rspA: 12.6	6dj1A-2rspA: 30.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DJ1_B_AB1B201_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.80A	6dj1B-2rspA: 12.7	6dj1B-2rspA: 30.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DJ2_B_AB1B201_1 (HIV-1 PROTEASE)	2rsp	RSV PROTEASE (Rous sarcoma virus)	5 / 12	ARG A  10 ASP A  37 GLY A  39 ALA A  40 ASP A  41	None	0.76A	6dj2B-2rspA: 12.7	6dj2B-2rspA: 30.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6F6S_B_CXQB705_1 (ENVELOPE GLYCOPROTEIN,ENVELOP E GLYCOPROTEIN,GP1 ENVELOPE GLYCOPROTEIN)	2rsp	RSV PROTEASE (Rous sarcoma virus)	4 / 6	VAL A  13 LEU A 109 LEU A 114 LEU A  95	None	1.05A	6f6sA-2rspA: undetectable 6f6sB-2rspA: undetectable	6f6sA-2rspA: 19.83 6f6sB-2rspA: 24.41